Company profile: Calon Cardio
1.1 - Company Overview
Company description
- Provider of implantable micro blood pumps for the treatment of chronic heart failure. Its Calon MiniVAD is a miniature implantable pump placed in the left ventricle to help provide blood supply to the body, alleviate debilitating symptoms, improve blood flow, and reduce complications such as blood damage and thrombus formation.
Products and services
- Calon MiniVAD™: Offered as a miniature implantable blood pump designed to assist the left ventricle in advanced chronic heart failure, improving blood flow while reducing blood damage and thrombus formation
- Left‑Ventricular Implant Program: Develops implantable micro blood pumps implanted into the left ventricle for chronic heart failure, helping provide blood supply to the body and alleviate debilitating symptoms
- Next‑Generation Implantable Micro‑Pump Development: Engineers implantable micro blood pumps for the treatment of heart failure, assisting the failing heart to help provide blood supply to the body and alleviate symptoms
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Calon Cardio
Hyloris Pharmaceuticals
HQ: Belgium
Website
- Description: Provider of specialty pharmaceutical therapies, including Sotalol IV for atrial fibrillation (developed with AltaThera), Maxigesic IV, a non-opioid analgesic for post-operative pain combining paracetamol and ibuprofen sodium dihydrate (developed with AFT Pharmaceuticals), and Podofilox Gel 0.5% for anogenital warts, equivalent to Condylox.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hyloris Pharmaceuticals company profile →
Caliber Therapeutics
HQ: United States
Website
- Description: Provider of stent-free targeted angioplasty drug delivery solutions, featuring the Virtue Sirolimus AngioInfusion Balloon, an investigational drug/device delivering extended-release sirolimus during balloon angioplasty without coating or permanent implant, and BackBeat Cardiac Neuromodulation Therapy, an investigational bioelectronic treatment for hypertension that modulates autonomic nervous system responses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Caliber Therapeutics company profile →
Vitatron
HQ: The Netherlands
Website
- Description: Provider of pacemakers—implanted devices that deliver timed electrical discharges to regulate slow or irregular heart rhythms—and the Vitatron 2090 Programmer, used to program and support advanced Vitatron cardiac devices to meet patient-specific needs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vitatron company profile →
Capstan Medical
HQ: United States
Website
- Description: Provider of minimally invasive catheter-based technologies for heart valve disorders, including the Capstan Platform for treating mitral and tricuspid valve disease while the heart is beating, precision heart valve implants placed through a catheter, and surgical robotics integration to enhance procedure accuracy and reliability, offering a less invasive alternative to open heart surgery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Capstan Medical company profile →
Intelesens
HQ: United Kingdom
Website
- Description: Provider of intelligent, wearable, non-invasive, wireless vital signs monitoring devices for hospital and home patient monitoring, leveraging proprietary high-sensitivity arrhythmia and respiratory algorithms, and offering defibrillation and ECG electrodes plus custom electrode design, prototyping, and end-to-end manufacturing compliant with international regulatory standards.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intelesens company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Calon Cardio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Calon Cardio
2.2 - Growth funds investing in similar companies to Calon Cardio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Calon Cardio
4.2 - Public trading comparable groups for Calon Cardio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →